Individual bioequivalence - A review of the FDA draft guidance

Drug Information Journal

Volumn 33, Issue 2, 1999, Pages 435-444

  Chow, Shein Chung ^a  

^a StatPlus Inc   (United States)

Author keywords

Brand name drugs; Food and Drug Administration; Generic drugs; Individual bioequivalence

Indexed keywords

BIOEQUIVALENCE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUSTRY; DRUG QUALITY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; IN VIVO STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

EID: 0033038778     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159903300215     Document Type: Review

References (18)

1. Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence. New York, NY: Marcel Dekker, Inc.: 1992.
2. FDA. Guidance on Statistical Procedures for Bioequivalence Studies Using a Standard Two-Treatment Crossover Design. Rockville, MD: Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; 1992.
3. Anderson S, Hauck WW. Consideration of individual bioequivalence. J Pharmacokin Biopharma. 1990;18:259-273.
4. FDA. Draft Guidance on In Vivo Bioequivalence Studies on Population and Individual Bioequivalence. Rockville, MD: Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; 1997.
5. Chen ML. Individual bioequivalence - a regulatory update. J Biopharma Stat. 1997;7:5-11.
6. Chow SC, Liu JP. Meta-analysis for bioequivalence review. J Biopharma Stat. 1997;7:97-111.
7. Liu JP, Chow SC. On the assessment of variability in bioavailability/bioequivalence studies. Comm Stat Theory Methods. 1992;21:2591-2608.
8. Liu JP, Chow SC. Some thoughts on individual bioequivalence. J Biopharma Stat. 1997;7(1):41-48.
9. Esinhart JD, Chinchilli VM. Extension to the use of tolerance intervals for assessment of individual bioequivalence. J Biopharma Stat. 1994;4:39-52.
10. Sheiner LB. Bioequivalence revisited. Stat Med. 1992;11:1777-1788.
11. Schall R, Luus RE. On population and individual bioequivalence. Stat Med. 1993;12:1109-1124.
12. Holder DJ, Hsuan F. Moment-based criteria for determining bioequivalence. Biometrika. 1993;80: 835-846.
13. Chow SC, Tse SK. Outliers detection in bioavailability/bioequivalence. Stat Med. 1990;9:549-558.
14. Liu JP, Weng CS. Detection of outlying data in bioavailability/bioequivalence studies. Stat Med. 1992; 10:1375-1389.
15. Chow SC, ed. Special issue on bioavailability and bioequivalence. Drug Inf J. 1995;29(3).
16. Chow SC, ed. Special issue on bioavailability and bioequivalence. J Biopharma Stat. 1997;7(1).
17. Chow SC, Liu JP, eds. Special issue on individual bioequivalence. Stat Med. 1999.
18. Chow SC. Current issues in bioequivalence trials. Drug Inf J. 1995;29(3):795-804.